N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-...

Details N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-... N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-...

2007-12-18

2010-06-15

Chu, Yong (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S406000, C544S371000, C548S364100

Reexamination Certificate

active

07737149

ABSTRACT:
There is provided a compound of formula (I):or a pharmaceutically acceptable salt thereof. There are also provided processes for the manufacture of a compound of Formula 1, and the use of a compound of Formula 1 as a medicament and in the treatment of cancer.

REFERENCES:
patent: 4407941 (1983-10-01), Suginaka et al.
patent: 5498630 (1996-03-01), Phillion et al.
patent: 5514529 (1996-05-01), Mihayashi et al.
patent: 5693667 (1997-12-01), Phillion et al.
patent: 5705513 (1998-01-01), Phillion et al.
patent: 5811411 (1998-09-01), Phillion et al.
patent: 5834447 (1998-11-01), Phillion et al.
patent: 5849723 (1998-12-01), Phillion et al.
patent: 5998466 (1999-12-01), Phillion et al.
patent: RE36562 (2000-02-01), Phillion et al.
patent: 6028101 (2000-02-01), Phillion et al.
patent: 6133252 (2000-10-01), Phillion et al.
patent: 6166057 (2000-12-01), Phillion et al.
patent: 6248894 (2001-06-01), Phillion et al.
patent: 6252078 (2001-06-01), Phillion et al.
patent: 6271237 (2001-08-01), Galemmo, Jr. et al.
patent: 6407114 (2002-06-01), Bunnage et al.
patent: 6410558 (2002-06-01), Phillion et al.
patent: 6521603 (2003-02-01), Phillion et al.
patent: 6548525 (2003-04-01), Galemmo, Jr. et al.
patent: 6552008 (2003-04-01), Duffy et al.
patent: 7015218 (2006-03-01), Ushio et al.
patent: 7034049 (2006-04-01), Pevarello et al.
patent: 7115359 (2006-10-01), Usagawa et al.
patent: 2001/0046975 (2001-11-01), Phillion et al.
patent: 2002/0016326 (2002-02-01), Galemmo, Jr. et al.
patent: 2003/0225106 (2003-12-01), Askew et al.
patent: 2004/0043904 (2004-03-01), Yamaguchi et al.
patent: 2004/0087616 (2004-05-01), Piotrowski et al.
patent: 2004/0220170 (2004-11-01), Atkinson et al.
patent: 2004/0259877 (2004-12-01), Muto et al.
patent: 2005/0020564 (2005-01-01), Atkinson et al.
patent: 2005/0037298 (2005-02-01), Usawaga et al.
patent: 2005/0070589 (2005-03-01), Ngu et al.
patent: 2005/0176965 (2005-08-01), Chen et al.
patent: 2005/0209297 (2005-09-01), Sanner et al.
patent: 2005/0245518 (2005-11-01), Delorme et al.
patent: 2006/0004010 (2006-01-01), Habashita et al.
patent: 2006/0019958 (2006-01-01), Muto et al.
patent: 2006/0111409 (2006-05-01), Muto et al.
patent: 2006/0116395 (2006-06-01), Piotrowski et al.
patent: 2006/0122243 (2006-06-01), Muto et al.
patent: 667399 (1965-11-01), None
patent: 1352650 (2001-12-01), None
patent: 1510207 (2003-06-01), None
patent: 1510210 (2003-06-01), None
patent: 1541544 (2003-06-01), None
patent: 1541563 (2003-07-01), None
patent: 843940 (1960-08-01), None
patent: 33010226 (1958-11-01), None
patent: 63133152 (1988-06-01), None
patent: 04184437 (1992-07-01), None
patent: 07188269 (1995-07-01), None
patent: 2890065 (1999-05-01), None
patent: 2004/067645 (2004-03-01), None
patent: 2004/292322 (2004-10-01), None
patent: 9319054 (1993-09-01), None
patent: 9415920 (1994-07-01), None
patent: 96/14843 (1996-05-01), None
patent: 9828269 (1998-07-01), None
patent: 9852941 (1998-11-01), None
patent: 9852944 (1998-11-01), None
patent: 0049001 (2000-08-01), None
patent: 01/12621 (2001-02-01), None
patent: 0112189 (2001-02-01), None
patent: 02/066470 (2002-08-01), None
patent: 02088090 (2002-11-01), None
patent: 2004/007458 (2004-01-01), None
patent: 2004/071440 (2004-08-01), None
patent: 2004/098518 (2004-11-01), None
patent: 2004/098528 (2004-11-01), None
patent: 2004/099156 (2004-11-01), None
patent: 2005/021537 (2005-03-01), None
patent: 2005048948 (2005-06-01), None
patent: 2005051919 (2005-06-01), None
patent: 2005105780 (2005-11-01), None
patent: 2006/116713 (2006-11-01), None
patent: 2007/016228 (2007-02-01), None
Pevarello et al. Journal of Medicinal Chemistry, (2004), 47(13), p. 3367-3380.
Fu et al, “Synthesis and purification of 3-N-acylaminopyrazolinones using a sequence of functionalized polymers”, Tetrahedron Letters (2003), 3843-3845, 44(19).
Hammad et al, “Synthesis of some new pyrazolones and benzimidazole acetonitriles derived from xanthene” , Egyptian Journal of Chemistry (1987), Volume Date 1986, 617-22, 29(6).
Kataeva et al, “Crystal and Molecular Structure of Acylalmino Derivatives of 1-(2,4,6-TrichlorophenyI)-4,5-dihydropyrazol-5-one”, Russian Journal of General Chemistry (Translation of Zhurnal Obshchei Khimii) (2003), 776-781, 73(5).
Peverello et al, “3-Aminopyrazole inhibitors of CDK2/Cyclin A as antitumour agents 1. Lead Finding”,J.Med.Chem., 2004, 3367-3380, 47.
Weissberger et Al, “Investigation of Pyrazole compounds. VII. Reaction of some hydrazines with Ethyl malonate monoimidoester”, Journal of the American Chemical Society (1944), 1851-5, 66.
Cavasotto et al: “In silico identification of novel EGFR inhibitors with antiproliferative activity against cancer cells” Bioorganic & Medicinal Chemistry Letters, Jan. 18, 2006, pp. 1969-1974, XP002487878, vol. 16.

Affiliated with

Also associated with

Rating

N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4197388